Petra Fiesel
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Circulating tumor DNA precision oncology enables effective and sensitive molecular diagnostics and actionable target detection in pediatric solid tumors - the INFORM experience.
Journal: Genome medicine
Published: February 17, 2026
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM.
Journal: Acta neuropathologica
Published: May 29, 2025
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targets.
Journal: Neuro-oncology advances
Published: February 03, 2025
Oncogene aberrations drive medulloblastoma progression, not initiation.
Journal: Nature
Published: January 03, 2024
3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.
Journal: Nature communications
Published: December 28, 2022
Patient-by-Patient Deep Transfer Learning for Drug-Response Profiling Using Confocal Fluorescence Microscopy of Pediatric Patient-Derived Tumor-Cell Spheroids.
Journal: IEEE transactions on medical imaging
Published: September 13, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.
Journal: NPJ precision oncology
Published: May 05, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models.
Journal: Cancers
Published: December 14, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.
Journal: Cancer discovery
Published: January 22, 2021
Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 22, 2019
Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
Journal: Journal of neuropathology and experimental neurology
Published: August 10, 2017
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 02, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026